iBet uBet web content aggregator. Adding the entire web to your favor.

In France, the revenue in the OTC Pharmaceuticals market is projected to reach US$4.40bn in 2024.
It is expected that the market will experience an annual growth rate of 2.75% (CAGR 2024-2029).
Among the various markets, the largest market is Other OTC Pharmaceuticals, with a market volume of US$1.47bn in 2024.
When compared globally, the United States generates the highest revenue, amounting to US$41.24bn in 2024.
Taking into account the population figures, the per person revenue in France is estimated to be US$67.86 in 2024.
Regarding the sales distribution channels, it is anticipated that online sales will contribute 20.05% of the total revenue in the OTC Pharmaceuticals market by 2024.
France's OTC Pharmaceuticals market is witnessing a growing demand for natural and herbal remedies as consumers prioritize holistic health and wellness.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in France is experiencing steady growth due to changing customer preferences and market trends. Customer preferences in the OTC Pharmaceuticals market in France are shifting towards self-medication and convenience. Consumers are increasingly seeking over-the-counter products that allow them to treat common ailments without the need for a doctor's prescription. This preference for self-medication is driven by factors such as convenience, cost-effectiveness, and the desire for quick relief from minor health issues. Additionally, the availability of a wide range of OTC products in pharmacies and supermarkets makes it easier for consumers to access and purchase these medications.Trends in the OTC Pharmaceuticals market in France are also contributing to its development. One notable trend is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This trend is fueled by a desire for more holistic and sustainable healthcare options. As a result, manufacturers are introducing more natural and herbal OTC products to cater to this demand.Another trend in the market is the increasing use of online platforms for purchasing OTC Pharmaceuticals. E-commerce has gained significant popularity in recent years, and consumers are now turning to online retailers to buy their healthcare products. The convenience of online shopping, coupled with the availability of a wide range of products and competitive pricing, has made it an attractive option for consumers. This trend has led to the growth of online pharmacies and the expansion of e-commerce platforms in the OTC Pharmaceuticals market in France.Local special circumstances in France also contribute to the development of the OTC Pharmaceuticals market. The country has a well-established healthcare system, with a strong emphasis on preventive care and self-medication. The French government encourages self-care and promotes the use of OTC medications for minor health issues. This supportive regulatory environment has created a favorable market for OTC Pharmaceuticals in France.Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in France. The country has a stable economy and a high standard of living, which allows consumers to afford OTC medications. Additionally, the aging population in France is driving the demand for OTC Pharmaceuticals, as older individuals are more likely to experience health issues that can be treated with these products. The increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, also contributes to the demand for OTC medications.In conclusion, the OTC Pharmaceuticals market in France is developing due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the demand for natural and herbal remedies, the rise of online platforms, and the supportive regulatory environment are all contributing to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.